SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000912057-00-020962
Filing Date
2000-05-02
Accepted
2000-05-02 00:00:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A SC 13G/A 11632
  Complete submission text file 0000912057-00-020962.txt   13465
Mailing Address
Business Address 201 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Subject) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-48459 | Film No.: 616662
SIC: 2834 Pharmaceutical Preparations

Mailing Address SUITE 922C EUROPORT (VIA LONDON) GIBRALTAR J1
Business Address STE 922C EUROPORT VIA LONDON GIBRALTAR J1 01135073440
KUMMELL INVESTMENTS LTD (Filed by) CIK: 0001032490 (see all company filings)

IRS No.: 000000000 | State of Incorp.: J1 | Fiscal Year End: 1231